Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines

by Marc Mansour, Genevieve M. Weir, Robert S. Liwski
Published 2011-08-01

Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.

by Genevieve M Weir, Mohan Karkada, David Hoskin, Marianne M Stanford, Lisa MacDonald, Marc Mansour, Robert S Liwski
Published 2017-01-01

Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines

by Drew R DeBay, Kimberly D Brewer, Sarah A LeBlanc, Genevieve M Weir, Marianne M Stanford, Marc Mansour, Chris V Bowen
Published 2015-01-01

A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model

by Timothy W. Phares, Vinayaka Kotraiah, Deshapriya S. Karunarathne, Jing Huang, Cecille D. Browne, Peter Buontempo, Marc Mansour, Amy R. Noe, Michelle N. Wykes, James Pannucci, Moriya Tsuji, Gabriel M. Gutierrez
Published 2020-07-01

Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

by Vinayaka Kotraiah, Timothy W. Phares, Cecille D. Browne, James Pannucci, Marc Mansour, Amy R. Noe, Kenneth D. Tucker, Jayne M. Christen, Charles Reed, Alecia MacKay, Genevieve M. Weir, Rajkannan Rajagopalan, Marianne M. Stanford, Chun-Shiang Chung, Alfred Ayala, Jing Huang, Moriya Tsuji, Gabriel M. Gutierrez
Published 2020-03-01